International Clinical Trial Oversight
ICH-GCP E6(R3) Transition, RBQM & Multi-Regional Clinical Trials
Aligning sponsor quality-by-design, decentralized trial technologies, and ICH E17 cross-border pooling with national REC oversight.
ICH-GCP E6(R3) replaces rigid one-size-fits-all monitoring with Quality by Design (QbD) and Risk-Based Quality Management (RBQM), requiring sponsors to concentrate oversight on Critical-to-Quality (CtQ) factors—primarily participant safety, informed consent integrity, and primary endpoint data reliability—across both conventional and decentralized trial sites.
Primary reference: ICH E6(R3) & E17 Efficacy Guidelines.
Multi-Regional Clinical Trials (ICH E17)
Under ICH E17, global drug development programs enroll participants across multiple regulatory jurisdictions simultaneously. While pooled regional sample sizing accelerates regulatory submission, ethics committees scrutinize whether intrinsic (pharmacogenomic, metabolic) and extrinsic (standard-of-care, diagnostic access) factors are transparently evaluated for the host population.
Sponsor & CRO Audit Readiness: TMF and SUSAR Timelines
Inspection readiness hinges on two operational disciplines: maintaining a contemporaneous Trial Master File (TMF) documenting every REC approval, protocol amendment, and delegation log; and enforcing strict pharmacovigilance escalation windows—7 calendar days for fatal or life-threatening SUSARs, and 15 calendar days for all other serious unexpected suspected adverse reactions.
| Governance Dimension | Legacy E6(R2) Practice | Modern E6(R3) Standard |
|---|---|---|
| Quality Architecture | 100% Source Data Verification (SDV) emphasis | Quality by Design (QbD) focused on Critical-to-Quality factors |
| Consent Modality | Paper wet-ink signatures default | Validated electronic informed consent (eConsent) & remote verification |
| Data Governance | Basic electronic data capture audit trails | End-to-end metadata, computerized system validation & ALCOA++ |
| Service Providers | CRO delegation with periodic audits | Clear sponsor accountability over decentralized home-health & ePRO vendors |